Edwards Lifesciences Share Holder Equity 2010-2025 | EW

Edwards Lifesciences share holder equity from 2010 to 2025. Share holder equity can be defined as the sum of preferred and common equity items
  • Edwards Lifesciences share holder equity for the quarter ending March 31, 2025 was $10.192B, a 41.82% increase year-over-year.
  • Edwards Lifesciences share holder equity for 2024 was $10.063B, a 49.76% increase from 2023.
  • Edwards Lifesciences share holder equity for 2023 was $6.719B, a 15.72% increase from 2022.
  • Edwards Lifesciences share holder equity for 2022 was $5.807B, a 0.5% decline from 2021.
Edwards Lifesciences Annual Share Holder Equity
(Millions of US $)
2024 $10,063
2023 $6,719
2022 $5,807
2021 $5,836
2020 $4,574
2019 $4,148
2018 $3,140
2017 $2,956
2016 $2,619
2015 $2,503
2014 $2,191
2013 $1,544
2012 $1,479
2011 $1,338
2010 $1,308
2009 $1,158
Edwards Lifesciences Quarterly Share Holder Equity
(Millions of US $)
2025-03-31 $10,192
2024-12-31 $10,063
2024-09-30 $9,611
2024-06-30 $7,505
2024-03-31 $7,186
2023-12-31 $6,719
2023-09-30 $6,727
2023-06-30 $6,447
2023-03-31 $6,062
2022-12-31 $5,807
2022-09-30 $6,218
2022-06-30 $5,944
2022-03-31 $5,845
2021-12-31 $5,836
2021-09-30 $5,541
2021-06-30 $5,133
2021-03-31 $4,658
2020-12-31 $4,574
2020-09-30 $4,210
2020-06-30 $3,839
2020-03-31 $3,901
2019-12-31 $4,148
2019-09-30 $3,815
2019-06-30 $3,500
2019-03-31 $3,448
2018-12-31 $3,140
2018-09-30 $3,361
2018-06-30 $3,164
2018-03-31 $3,246
2017-12-31 $2,956
2017-09-30 $3,163
2017-06-30 $2,940
2017-03-31 $2,743
2016-12-31 $2,619
2016-09-30 $2,692
2016-06-30 $2,471
2016-03-31 $2,299
2015-12-31 $2,503
2015-09-30 $2,421
2015-06-30 $2,289
2015-03-31 $2,214
2014-12-31 $2,191
2014-09-30 $2,043
2014-06-30 $1,915
2014-03-31 $1,341
2013-12-31 $1,544
2013-09-30 $1,437
2013-06-30 $1,580
2013-03-31 $1,592
2012-12-31 $1,479
2012-09-30 $1,536
2012-06-30 $1,435
2012-03-31 $1,390
2011-12-31 $1,338
2011-09-30 $1,355
2011-06-30 $1,385
2011-03-31 $1,358
2010-12-31 $1,308
2010-09-30 $1,234
2010-06-30 $1,118
2010-03-31 $1,152
2009-12-31 $1,158
2009-09-30 $1,090
2009-06-30 $1,003
2009-03-31 $943
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $45.655B $5.440B
Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care.
Stock Name Country Market Cap PE Ratio
Intuitive Surgical (ISRG) United States $199.696B 87.47
Thermo Fisher Scientific (TMO) United States $156.188B 18.89
Alcon (ALC) Switzerland $43.440B 29.36
IDEXX Laboratories (IDXX) United States $41.591B 47.80
DexCom (DXCM) United States $34.247B 52.93
IQVIA Holdings (IQV) United States $25.076B 14.05
Mettler-Toledo (MTD) United States $24.648B 29.31
STERIS (STE) Ireland $24.609B 27.14
Waters (WAT) United States $21.548B 30.40
SONOVA HOLDING (SONVY) Switzerland $20.213B 0.00
Hologic (HOLX) United States $12.584B 13.67
Penumbra (PEN) United States $10.887B 85.45
Sysmex ADR (SSMXY) Japan $10.571B 29.99
Globus Medical (GMED) United States $8.473B 19.87
Masimo (MASI) United States $8.467B 31.23
Teleflex (TFX) United States $5.606B 9.25
Glaukos (GKOS) United States $5.571B 0.00
Integer Holdings (ITGR) United States $4.243B 22.23
TransMedics (TMDX) United States $4.218B 91.70
PROCEPT BioRobotics (PRCT) United States $3.274B 0.00
LivaNova (LIVN) United Kingdom $2.447B 14.57
Veracyte (VCYT) United States $2.256B 31.66
Elekta AB (EKTAY) Sweden $2.106B 18.93
Nihon Kohden (NHNKY) Japan $2.058B 23.60
Alphatec Holdings (ATEC) United States $1.896B 0.00
Tandem Diabetes Care (TNDM) United States $1.567B 0.00
Artivion (AORT) United States $1.246B 116.68
Pulse Biosciences (PLSE) United States $1.148B 0.00
OPKO Health (OPK) United States $1.055B 0.00
Integra LifeSciences Holdings (IART) United States $1.035B 5.50
SiBone (SIBN) United States $0.840B 0.00
Beta Bionics (BBNX) United States $0.687B 0.00
IRadimed (IRMD) United States $0.678B 34.38
RxSight (RXST) United States $0.675B 0.00
Mesa Laboratories (MLAB) United States $0.627B 13.70
Delcath Systems (DCTH) United States $0.626B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.606B 9.42
NeuroPace (NPCE) United States $0.590B 0.00
OrthoPediatrics (KIDS) United States $0.556B 0.00
AxoGen (AXGN) United States $0.527B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.468B 0.00
Semler Scientific (SMLR) United States $0.467B 12.43
Treace Medical Concepts (TMCI) United States $0.421B 0.00
AngioDynamics (ANGO) United States $0.386B 0.00
ClearPoint Neuro (CLPT) United States $0.358B 0.00
Pacific Biosciences Of California (PACB) United States $0.306B 0.00
Neuronetics (STIM) United States $0.282B 0.00
Tactile Systems Technology (TCMD) United States $0.242B 14.65
Alpha Tau Medical (DRTS) Israel $0.229B 0.00
CVRx (CVRX) United States $0.182B 0.00
Accuray (ARAY) United States $0.179B 0.00
908 Devices (MASS) United States $0.177B 0.00
Spectral Diagnostics (EDTXF) Canada $0.173B 0.00
Sight Sciences (SGHT) United States $0.169B 0.00
Inogen (INGN) United States $0.169B 0.00
LENSAR (LNSR) United States $0.165B 0.00
Lucid Diagnostics (LUCD) United States $0.141B 0.00
Rapid Micro Biosystems (RPID) United States $0.140B 0.00
Anteris Technologies Global (AVR) Australia $0.138B 0.00
KORU Medical Systems (KRMD) United States $0.136B 0.00
Atossa Genetics (ATOS) United States $0.122B 0.00
Monogram Orthopaedics (MGRM) United States $0.099B 0.00
Microbot Medical (MBOT) United States $0.095B 0.00
Biosig Technologies (BSGM) United States $0.084B 0.00
Sensus Healthcare (SRTS) United States $0.079B 48.00
EDAP TMS S.A (EDAP) France $0.071B 0.00
InspireMD (NSPR) Israel $0.067B 0.00
EnVVeno Medical (NVNO) United States $0.066B 0.00
Covalon Technologies (CVALF) Canada $0.056B 17.08
Hyperfine (HYPR) United States $0.048B 0.00
Vicarious Surgical (RBOT) United States $0.044B 0.00
Envoy Medical (COCH) United States $0.037B 0.00
Spectral AI (MDAI) United States $0.034B 0.00
Precision Optics (POCI) United States $0.034B 0.00
Baird Medical Investment Holdings (BDMD) $0.033B 0.00
DarioHealth (DRIO) United States $0.030B 0.00
Adagio Medical Holdings (ADGM) United States $0.018B 0.00
NexGel (NXGL) United States $0.018B 0.00
PAVmed (PAVM) United States $0.011B 0.00
Ekso Bionics Holdings (EKSO) United States $0.010B 0.00
Tenon Medical (TNON) United States $0.009B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.008B 0.00
WORK Medical Technology Group (WOK) China $0.007B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.006B 0.00
Check-Cap (CHEK) Israel $0.005B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
ReShape Lifesciences (RSLS) United States $0.004B 0.00
Nuwellis (NUWE) United States $0.004B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.001B 0.00
Nanovibronix (NAOV) United States $0.001B 0.00
Accelerate Diagnostics (AXDX) United States $0.001B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $0.000B 17.06
Longview Acquisition II (LGV) United States $0.000B 0.00